J&J wins FDA nod for Tecnis PureSee intraocular lens

Johnson & Johnson (JNJ) announced on Thursday that the U.S. Food and Drug Administration (FDA) approved its Tecnis PureSee intraocular lens (IOL), giving eye surgeons a new lens option for use in ...
Medical Device and Diagnostic Industry (MD+DI)

FDA Approves Johnson & Johnson's Breakthrough Cataracts Solution

The Tecnis PureSee IOL is the first FDA-approved extended depth of focus IOL maintaining contrast sensitivity comparable to ...
MassDevice

Johnson & Johnson wins FDA nod for new intraocular lens

Johnson & Johnson (NYSE: JNJ) announced that it received FDA approval for its Tecnis PureSee intraocular lens (IOL) for ...
Ophthalmology Times

FDA approves Johnson & Johnson's TECNIS PureSee EDOF IOL

FDA approval supports US commercialization of TECNIS PureSee, an EDOF IOL for implantation during cataract surgery, with ...
Monthly Prescribing Reference

FDA Approves Small Aperture Intraocular Lens for Cataract Patients

The device is intended for primary implantation in the capsular bag, in the nondominant eye, after the fellow eye has already undergone successful implantation of a monofocal or monofocal toric IOL ...
GlobalData on MSN

FDA approves J&J’s TECNIS PureSee intraocular lens

The TECNIS PureSee IOL addresses both cataract-related vision loss and presbyopia, which affects near vision as eyes age.